Thomas J Tisch's Net Worth
-$50.9 Million
Who is Thomas J Tisch?
Thomas J Tisch does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ANTEON INTERNATIONAL CORP, INCYTE CORP, SYNAGEVA BIOPHARMA CORP, SEARS HOLDINGS CORP, KMART HOLDING CORP, CELLEGY PHARMACEUTICALS INC, and NEUROGEN CORP.
SEC CIK
Thomas J Tisch's CIK is 0001081916
Past Insider Trading and Trends
2014 was Thomas J Tisch's most active year for acquiring shares with 5 total transactions. Thomas J Tisch's most active month to acquire stocks was the month of December. 2015 was Thomas J Tisch's most active year for disposing of shares, totalling 4 transactions. Thomas J Tisch's most active month to dispose stocks was the month of May. 2012 saw Thomas J Tisch paying a total of $34,741,400.00 for 1,371,500 shares, this is the most they've acquired in one year. In 2015 Thomas J Tisch cashed out on 408,435 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANTEON INTERNATIONAL CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +950.00% | 9.5K |
$18.59 | $176,625.00 | 10.5K |
Oct 17
| |||
Form 4
|
∞
| 1K |
—
|
—
| 1K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
| No matching records found | |||||||||
INCYTE CORP (INCY) Snapshot price: $60.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +22.03% | 255.75K |
$5.50 | $1,406,625.00 | 1.42M |
Aug 12
| |||
Form 4
| +22.03% | 255.75K |
$5.50 | $1,406,625.00 | 1.42M |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
| No matching records found | |||||||||
SYNAGEVA BIOPHARMA CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -752.00K |
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +5.97% | 21.04K |
$47.53 | $999,983.67 | 373.56K |
Jan 9
| |||
Form 4
| +11.09% | 73K |
$41.20 | $3,007,600.00 | 730.96K |
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4/A
| +54.07% | 120K |
$25.18 | $3,021,600.00 | 341.94K |
Jan 10
| |||
Form 4
|
∞
| 1.2M |
$25.18 | $30,216,000.00 | 341.94K |
Jan 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SEARS HOLDINGS CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
| +15.00% | 233.09K |
—
|
—
| 1.79M |
Jan 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
| +325.74% | 475K |
$33.56 | $15,940,000.00 | 620.82K |
Apr 15 - Apr 16
| |||
| No matching records found | |||||||||
KMART HOLDING CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||